Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1

(2013) Se Won Kim et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Low-density Lipoprotein Cholesterol/Apolipoprotein B Ratio May Be a Useful Index That Differs in Statin-Treated Patients With and Without Coronary Artery Disease

(2011) Shigemasa Tani et al.   International Heart Journal

Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study

(2010) Noora Mattsson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis

(2010) William P. Arend et al.   ARTHRITIS AND RHEUMATISM

Plasma lecithin:cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men

(2009) R.P.F. Dullaart et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis

(2009) Jozélio Freire de Carvalho et al.   CLINICAL RHEUMATOLOGY

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

(2008) A. Blum et al.   ATHEROSCLEROSIS

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

(2008) J. Sierra-Johnson et al.   EUROPEAN HEART JOURNAL

Takayasu’s disease presenting with atherothrombotic ischaemic stroke

(2008) Key-Chung Park et al.   NEUROLOGICAL SCIENCES